Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases

Saved in:
Bibliographic Details
Published inJoint, bone, spine : revue du rhumatisme Vol. 88; no. 6; pp. 105226 - 4
Main Authors Trefond, Ludovic, Drumez, Elodie, Andre, Marc, Costedoat-Chalumeau, Nathalie, Seror, Raphaèle, Devaux, Mathilde, Dernis, Emmanuelle, Dieudonné, Yannick, El Mahou, Soumaya, Lanteri, Aurelia, Melki, Isabelle, Queyrel, Viviane, Roumier, Mathilde, Schmidt, Jean, Barnetche, Thomas, Thomas, Thierry, Cacoub, Patrice, Belot, Alexandre, Aumaitre, Olivier, Richez, Christophe, Hachulla, Eric
Format Journal Article
LanguageEnglish
Published Elsevier Masson SAS 01.12.2021
Elsevier Masson
Société française de rhumatologie. Published by Elsevier Masson SAS
Subjects
COVID-19
DMARD
Hydroxychloroquine
Inflammatory rheumatic and musculoskeletal diseases
Letter to the Editor
Life Sciences
Microbiology and Parasitology
SARS COV-2 evolution
SARS CoV-2 tests
COVID-19
Inflammatory rheumatic and musculoskeletal diseases
DMARD
SARS CoV-2 tests
Hydroxychloroquine
SARS COV-2 evolution
Online AccessGet full text

Cover

ArticleNumber 105226
Author Hachulla, Eric
Trefond, Ludovic
Thomas, Thierry
Barnetche, Thomas
Belot, Alexandre
Dernis, Emmanuelle
Roumier, Mathilde
Lanteri, Aurelia
Drumez, Elodie
Melki, Isabelle
Andre, Marc
Richez, Christophe
Queyrel, Viviane
Schmidt, Jean
Seror, Raphaèle
Dieudonné, Yannick
Cacoub, Patrice
Costedoat-Chalumeau, Nathalie
Devaux, Mathilde
El Mahou, Soumaya
Aumaitre, Olivier
Author_xml – sequence: 1
  givenname: Ludovic
  surname: Trefond
  fullname: Trefond, Ludovic
  email: ltrefond@chu-clermontferrand.fr
  organization: Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied, Inserm U1071, INRA USC2018, M2iSH, 63000 Clermont-Ferrand, France
– sequence: 2
  givenname: Elodie
  surname: Drumez
  fullname: Drumez, Elodie
  organization: Université de Lille, CHU Lille, ULR 2694-METRICS: Évaluation des technologies de santé et des pratiques médicales, 59000 Lille, France
– sequence: 3
  givenname: Marc
  surname: Andre
  fullname: Andre, Marc
  organization: Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied, Inserm U1071, INRA USC2018, M2iSH, 63000 Clermont-Ferrand, France
– sequence: 4
  givenname: Nathalie
  surname: Costedoat-Chalumeau
  fullname: Costedoat-Chalumeau, Nathalie
  organization: APHP, Service de Médecine Interne, Centre de Référence des Maladies Auto-immunes Systémiques Rares d’Ile de France, Hôpital Cochin, Université de Paris, INSERM U 1153, Centre of Research in Epidemiology and Statistics Sorbonne Paris Cité (CRESS), 27 rue du Faubourg St-Jacques, 75679 Paris cedex 14, France
– sequence: 5
  givenname: Raphaèle
  surname: Seror
  fullname: Seror, Raphaèle
  organization: Université Paris-Saclay, Assistance Publique–Hôpitaux de Paris (AP-HP), Service de Rhumatologie, Centre de référence des maladies autoimmunes systémiques rares, Hôpital Bicêtre, INSERM UMR 1184, Le Kremlin-Bicêtre, France
– sequence: 6
  givenname: Mathilde
  surname: Devaux
  fullname: Devaux, Mathilde
  organization: Service de Médecine Interne, CHI Poissy Saint-Germain, France
– sequence: 7
  givenname: Emmanuelle
  surname: Dernis
  fullname: Dernis, Emmanuelle
  organization: Department of Rheumatology, General Hospital, Le Mans, France
– sequence: 8
  givenname: Yannick
  surname: Dieudonné
  fullname: Dieudonné, Yannick
  organization: Hôpitaux universitaires de Strasbourg, Department of Clinical Immunology and Internal Medicine, National Reference Centre for Systemic Autoimmune Diseases (CNR RESO), 67000 Strasbourg, France
– sequence: 9
  givenname: Soumaya
  surname: El Mahou
  fullname: El Mahou, Soumaya
  organization: Service de rhumatologie, CH DRON, 59200 Tourcoing, France
– sequence: 10
  givenname: Aurelia
  surname: Lanteri
  fullname: Lanteri, Aurelia
  organization: Service de médecine interne, CH Antibes, France
– sequence: 11
  givenname: Isabelle
  surname: Melki
  fullname: Melki, Isabelle
  organization: General Paediatrics, Infectious Disease and Internal Medicine Department, Hôpital Robert-Debré, AP-HP, Reference centre for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Paediatric Haematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, Reference centre for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, Paris, France
– sequence: 12
  givenname: Viviane
  surname: Queyrel
  fullname: Queyrel, Viviane
  organization: Service de rhumatologie/Centre de compétence des maladies auto-immunes systémiques rares, Hôpital Pasteur 2, CHU Nice, 30 avenue Voie romaine, 06000 Nice, France
– sequence: 13
  givenname: Mathilde
  surname: Roumier
  fullname: Roumier, Mathilde
  organization: Service de Médecine Interne, Hôpital FOCH, Suresnes, France
– sequence: 14
  givenname: Jean
  surname: Schmidt
  fullname: Schmidt, Jean
  organization: Université de Picardie Jules Verne, CHU Amiens, Service de Médecine Interne et RECIF, Amiens, France
– sequence: 15
  givenname: Thomas
  surname: Barnetche
  fullname: Barnetche, Thomas
  organization: Hôpital Pellegrin, CHU de Bordeaux, Service de Rhumatologie, Centre de référence des maladies autoimmunes systémiques rares (RESO), UMR-CNRS 5164, Université de Bordeaux, Bordeaux, France
– sequence: 16
  givenname: Thierry
  surname: Thomas
  fullname: Thomas, Thierry
  organization: Department of Rheumatology, Hôpital Nord, CHU Saint-Étienne, Inserm U1059, Université de Lyon-Université Jean-Monnet, Saint-Étienne, France
– sequence: 17
  givenname: Patrice
  surname: Cacoub
  fullname: Cacoub, Patrice
  organization: AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Department of Internal Medicine and Clinical Immunology, 75013, Paris, France
– sequence: 18
  givenname: Alexandre
  surname: Belot
  fullname: Belot, Alexandre
  organization: Paediatric Rheumatology, Nephrology, Dermatology Unit, National Reference Centre for Rheumatism and Systemic Autoimmune Diseases in Children (RAISE), Hospices Civils de Lyon, France
– sequence: 19
  givenname: Olivier
  surname: Aumaitre
  fullname: Aumaitre, Olivier
  organization: Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Médecine Interne, Hôpital Gabriel Montpied, Inserm U1071, INRA USC2018, M2iSH, 63000 Clermont-Ferrand, France
– sequence: 20
  givenname: Christophe
  surname: Richez
  fullname: Richez, Christophe
  organization: Hôpital Pellegrin, CHU de Bordeaux, Service de Rhumatologie, Centre de référence des maladies autoimmunes systémiques rares (RESO), UMR-CNRS 5164, Université de Bordeaux, Bordeaux, France
– sequence: 21
  givenname: Eric
  surname: Hachulla
  fullname: Hachulla, Eric
  organization: Université de Lille, Inserm, CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), U1286-INFINITE-Institute for Translational Research in Inflammation, 59000 Lille, France
BackLink https://hal.inrae.fr/hal-03318617$$DView record in HAL
BookMark eNqFUsuO0zAUjdAg5gF_wMJLWKT4EeeBEFLVAWakIqQZQOws17kh7jh2xk4K_Sp-EactC7rpyvd1jo_OvZfJmXUWkuQlwTOCSf5mPVuvQq_tjGJKYolTmj9JLkhRlGlBeXYWY1oVKSPVj_PkMoQ1xphRnj9LzlmGOWElv0j-3Ha9VANyDWq3tXe_t6o1zrvHUVtAY4AayYCuP8_vrpGz6H5-d58u3PeUogHCEJC0NdK2ATXo2IaNM-Mu0hZJ1Lt-NHKXR_6yIKiPGdiI-6WHdgIa2XVycH6LfAtjDLXacXZjUKNx4QEMDNKgWgeQAcLz5GkjTYAXh_cq-fbxw9fFTbr88ul2MV-mitNiSGldVRVnfFVLqRqoGlrSWsWaXMkVNKrJJC8qRXCmZINLomhsAcsLpqJFvGJXyfs9bz-uOqhVFO2lEb3XnfRb4aQW_3esbsVPtxEl4ZTlJBK83hO0R7Cb-VJMNcwYKXNSbKbZV4fPJuOjr6LTQYEx0oIbg6CcZTnBFZ10vd2PKu9C8NAIpYedxVGFNoJgMV2HWIv9dYjpOsT-OiI4OwL_E3YCdvACouEbDV4EFbeooNY-Ll7UTp8ieHdEoIy2WknzANvT8L_U_u84
CitedBy_id crossref_primary_10_1136_annrheumdis_2021_221575
crossref_primary_10_1177_03000605221090363
crossref_primary_10_1002_acr2_11481
crossref_primary_10_1016_j_intimp_2021_108254
Cites_doi 10.1038/s41586-020-2521-4
10.1002/art.39194
10.1038/s41584-020-0372-x
10.1016/j.ijantimicag.2020.105949
10.1093/cid/ciaa237
10.1136/annrheumdis-2020-218310
10.1038/s41422-020-0282-0
10.7326/M20-4207
10.1056/NEJMe2020388
10.1056/NEJMoa2012410
ContentType Journal Article
Copyright 2021 Société française de rhumatologie
Attribution - NonCommercial - NoDerivatives
2021 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved. 2021 Société française de rhumatologie
Copyright_xml – notice: 2021 Société française de rhumatologie
– notice: Attribution - NonCommercial - NoDerivatives
– notice: 2021 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved. 2021 Société française de rhumatologie
CorporateAuthor FAI2R SFR SNFMI SOFREMIP CRI IMIDIATE consortium contributors
CorporateAuthor_xml – name: FAI2R SFR SNFMI SOFREMIP CRI IMIDIATE consortium contributors
DBID AAYXX
CITATION
7X8
1XC
5PM
DOI 10.1016/j.jbspin.2021.105226
DatabaseName CrossRef
MEDLINE - Academic
Hyper Article en Ligne (HAL)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1778-7254
EndPage 4
ExternalDocumentID PMC8152361
oai_HAL_hal_03318617v1
10_1016_j_jbspin_2021_105226
S1297319X21000993
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1~.
1~5
29J
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
LN9
M41
MO0
N9A
O-L
O9-
OAUVE
OI0
OV-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SDF
SDG
SEM
SES
SEW
SPCBC
SSH
SSZ
T5K
UHS
Z5R
~G-
AACTN
AAIAV
ABLVK
ABYKQ
AFCTW
AFKWA
AJBFU
AJOXV
AMFUW
EFLBG
LCYCR
RIG
AAYXX
AGRNS
CITATION
7X8
1XC
5PM
ID FETCH-LOGICAL-c527t-2d999535bdaacfe9f282dc999ababefcf4a579c104caf081c299ae3673c325593
IEDL.DBID .~1
ISSN 1297-319X
1778-7254
IngestDate Thu Aug 21 17:50:38 EDT 2025
Fri Aug 22 06:20:16 EDT 2025
Fri Jul 11 02:16:07 EDT 2025
Tue Jul 01 04:18:49 EDT 2025
Thu Apr 24 23:10:50 EDT 2025
Fri Feb 23 02:40:32 EST 2024
Tue Aug 26 16:32:50 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords COVID-19
Inflammatory rheumatic and musculoskeletal diseases
DMARD
SARS CoV-2 tests
Hydroxychloroquine
SARS COV-2 evolution
Language English
License Attribution - NonCommercial - NoDerivatives: http://creativecommons.org/licenses/by-nc-nd
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c527t-2d999535bdaacfe9f282dc999ababefcf4a579c104caf081c299ae3673c325593
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 23
PMCID: PMC8152361
List of consortium and contributors is available in Online material, supplementary data S3.
ORCID 0000-0001-5959-9183
0000-0002-1555-9021
0000-0001-7432-847X
0000-0001-5454-903X
0000-0002-3029-8739
0000-0002-6727-4992
0000-0002-8057-333X
0000-0002-0975-8534
0000-0003-4027-7875
0000-0003-4902-5332
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8152361
PMID 34051385
PQID 2534610929
PQPubID 23479
PageCount 4
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8152361
hal_primary_oai_HAL_hal_03318617v1
proquest_miscellaneous_2534610929
crossref_citationtrail_10_1016_j_jbspin_2021_105226
crossref_primary_10_1016_j_jbspin_2021_105226
elsevier_sciencedirect_doi_10_1016_j_jbspin_2021_105226
elsevier_clinicalkey_doi_10_1016_j_jbspin_2021_105226
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-12-01
PublicationDateYYYYMMDD 2021-12-01
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-01
  day: 01
PublicationDecade 2020
PublicationTitle Joint, bone, spine : revue du rhumatisme
PublicationYear 2021
Publisher Elsevier Masson SAS
Elsevier Masson
Société française de rhumatologie. Published by Elsevier Masson SAS
Publisher_xml – name: Elsevier Masson SAS
– name: Elsevier Masson
– name: Société française de rhumatologie. Published by Elsevier Masson SAS
References (bib0070) 2021; 80
Yao, Ye, Zhang (bib0060) 2020; 71
Cohen (bib0100) 2020; 383
Gautret, Lagier, Parola (bib0065) 2020; 56
Skipper, Pastick, Engen (bib0090) 2020; 173
Wang, Cao, Zhang (bib0055) 2020; 30
Schrezenmeier, Dörner (bib0085) 2020; 16
Jallouli, Galicier, Zahr (bib0080) 2015; 67
Geleris, Sun, Platt (bib0095) 2020; 382
Williamson, Walker, Bhaskaran (bib0075) 2020; 584
Williamson (10.1016/j.jbspin.2021.105226_bib0075) 2020; 584
Jallouli (10.1016/j.jbspin.2021.105226_bib0080) 2015; 67
Gautret (10.1016/j.jbspin.2021.105226_bib0065) 2020; 56
Cohen (10.1016/j.jbspin.2021.105226_bib0100) 2020; 383
Yao (10.1016/j.jbspin.2021.105226_bib0060) 2020; 71
Schrezenmeier (10.1016/j.jbspin.2021.105226_bib0085) 2020; 16
(10.1016/j.jbspin.2021.105226_bib0070) 2021; 80
Wang (10.1016/j.jbspin.2021.105226_bib0055) 2020; 30
Geleris (10.1016/j.jbspin.2021.105226_bib0095) 2020; 382
Skipper (10.1016/j.jbspin.2021.105226_bib0090) 2020; 173
References_xml – volume: 173
  start-page: 623
  year: 2020
  end-page: 631
  ident: bib0090
  article-title: Hydroxychloroquine in non-hospitalized adults with early COVID-19: a randomized trial
  publication-title: Ann Intern Med
– volume: 382
  start-page: 2411
  year: 2020
  end-page: 2418
  ident: bib0095
  article-title: Observational study of hydroxychloroquine in hospitalized patients with COVID-19
  publication-title: N Engl J Med
– volume: 16
  start-page: 155
  year: 2020
  end-page: 166
  ident: bib0085
  article-title: Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
  publication-title: Nat Rev Rheumatol
– volume: 584
  start-page: 430
  year: 2020
  end-page: 436
  ident: bib0075
  article-title: Factors associated with COVID-19-related death using OpenSAFELY
  publication-title: Nature
– volume: 67
  start-page: 2176
  year: 2015
  end-page: 2184
  ident: bib0080
  article-title: Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus
  publication-title: Arthritis Rheumatol
– volume: 383
  start-page: 585
  year: 2020
  end-page: 586
  ident: bib0100
  article-title: Hydroxychloroquine for the prevention of COVID-19 – searching for evidence
  publication-title: N Engl J Med
– volume: 56
  start-page: 105949
  year: 2020
  ident: bib0065
  article-title: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
  publication-title: Int J Antimicrob Agents
– volume: 71
  start-page: 732
  year: 2020
  end-page: 739
  ident: bib0060
  article-title: In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  publication-title: Clin Infect Dis
– volume: 80
  start-page: 527
  year: 2021
  end-page: 538
  ident: bib0070
  article-title: Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
  publication-title: Ann Rheum Dis
– volume: 30
  start-page: 269
  year: 2020
  end-page: 271
  ident: bib0055
  article-title: Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
  publication-title: Cell Res
– volume: 584
  start-page: 430
  year: 2020
  ident: 10.1016/j.jbspin.2021.105226_bib0075
  article-title: Factors associated with COVID-19-related death using OpenSAFELY
  publication-title: Nature
  doi: 10.1038/s41586-020-2521-4
– volume: 67
  start-page: 2176
  year: 2015
  ident: 10.1016/j.jbspin.2021.105226_bib0080
  article-title: Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.39194
– volume: 16
  start-page: 155
  year: 2020
  ident: 10.1016/j.jbspin.2021.105226_bib0085
  article-title: Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/s41584-020-0372-x
– volume: 56
  start-page: 105949
  year: 2020
  ident: 10.1016/j.jbspin.2021.105226_bib0065
  article-title: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
  publication-title: Int J Antimicrob Agents
  doi: 10.1016/j.ijantimicag.2020.105949
– volume: 71
  start-page: 732
  year: 2020
  ident: 10.1016/j.jbspin.2021.105226_bib0060
  article-title: In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciaa237
– volume: 80
  start-page: 527
  year: 2021
  ident: 10.1016/j.jbspin.2021.105226_bib0070
  article-title: Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2020-218310
– volume: 30
  start-page: 269
  year: 2020
  ident: 10.1016/j.jbspin.2021.105226_bib0055
  article-title: Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
  publication-title: Cell Res
  doi: 10.1038/s41422-020-0282-0
– volume: 173
  start-page: 623
  year: 2020
  ident: 10.1016/j.jbspin.2021.105226_bib0090
  article-title: Hydroxychloroquine in non-hospitalized adults with early COVID-19: a randomized trial
  publication-title: Ann Intern Med
  doi: 10.7326/M20-4207
– volume: 383
  start-page: 585
  year: 2020
  ident: 10.1016/j.jbspin.2021.105226_bib0100
  article-title: Hydroxychloroquine for the prevention of COVID-19 – searching for evidence
  publication-title: N Engl J Med
  doi: 10.1056/NEJMe2020388
– volume: 382
  start-page: 2411
  year: 2020
  ident: 10.1016/j.jbspin.2021.105226_bib0095
  article-title: Observational study of hydroxychloroquine in hospitalized patients with COVID-19
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2012410
SSID ssj0003256
Score 2.3256333
SourceID pubmedcentral
hal
proquest
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 105226
SubjectTerms COVID-19
DMARD
Hydroxychloroquine
Inflammatory rheumatic and musculoskeletal diseases
Letter to the Editor
Life Sciences
Microbiology and Parasitology
SARS COV-2 evolution
SARS CoV-2 tests
Title Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1297319X21000993
https://dx.doi.org/10.1016/j.jbspin.2021.105226
https://www.proquest.com/docview/2534610929
https://hal.inrae.fr/hal-03318617
https://pubmed.ncbi.nlm.nih.gov/PMC8152361
Volume 88
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGkBAviE9RPqYD8Rq62EmzPEYdU0fpHloGfbNsx1E6WFIt7SRe-Jf4F7lznLJISEM8VXXskxWf734Xn3_H2DsMGYQOIx2E1uggylOOWyrFYEVh_IHWb3TkGPhmZ6PJefRxGS_32Li7C0Npld72tzbdWWvfMvRvc7herYaL0JVdSpc8dDiHGD-jKCEtf__zT5qH4K6CK3UOqHd3fc7leF3oZr0iFlQeUsFbThQLf3dPd0rKk7wBQvsplDd80slD9sCDScja-T5ie7Z6zO7N_HH5E_br1N2BhLqA8kdOCSumxPgcheNj2DY2B9XA8SybH0NdwSKbL4Jx_SXggAB004CqcuiytSqw115NsQ0UrHelv0g-RkTgOVoboI-7NBC17dKd4sNVabeOHNbJvNxS-mvdfEOfh-Af_ClR85Sdn3z4PJ4EvkJDYGKebAKeI76MRaxzpUxh0wIDuNxgm9JK28IUkYqT1GDIZ1SB4MOg81NWjBJhBMUy4hnbr-rKPmcgRqE2GsFHhBFhhDDGoIicm8MCQ86iiAZMdAsjjacvpyoa32WXp3Yh2-WUtJyyXc4BC3aj1i19xy39427NZXc1FY2pRP9yy7hkN66nvv8w8i2q1m5yxPY9yT5JajsUaHARYV6HA_am0zyJ25_OdFRl620jeSwcYz5PcQo9leyJ7D-pVqUjEj9C8Ibv_cV_T_4lu0__2vSeV2x_c7W1rxGkbfSB24UH7G52Op2c0e90_nX6G9JeQTw
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdtCttexj5p1n1oY68mtWQn9aNJV5w1yUPTjrwJSZZxutUOdVzoX7V_cXeybGoYdOxV8h3Cdz79zjr9jpCvkDJw5QfK841WXpBGDD6pCJIVCfkHRL_xiWXgWyzHyVXwfR2u98i0vQuDZZUu9jcx3UZrNzJyb3O03WxGK9-2XYrWzLc4h--TA2SnCgfkIJ6dJ8suIHNmm7ji8x4KtDfobJnXtaq2GyRCZT72vGXIsvD3HWo_x1LJBzi0X0X5YFs6e0GeOzxJ42bJL8meKV6RJwt3Yv6a_J7Za5C0zGh-n2LNis4hRQflME3ryqRUVvR0EV-c0rKgq_hi5U3LHx6jgEF3FZVFStuCrYKaO-epMEYl3Xbdv1A_JEXU0bRWFP_voiA43I09yKe3uaktP6zVeVNjBWxZ_YRtD_A_dQdF1Rtydfbtcpp4rkmDp0M22XksBYgZ8lClUurMRBnkcKmGMamkMpnOAhlOIg1Zn5YZ4A8N-580fDzhmmM6w9-SQVEW5pBQPvaVVoA_AkgKA0AyGlSkTB9nkHVmWTAkvDWM0I7BHBtp_BJtqdq1aMwp0JyiMeeQeJ3UtmHweOT5sLW5aG-nQjwVsMU8Ijfp5Hoe_A-SX8C1usUh4XcSzwWOHXOIuQAy7_wh-dx6noAIgMc6sjBlXQkWckuazyJYQs8leyr7M8Umt1ziJ4Df4L2_--_FfyJPk8vFXMxny_Mj8gxnmmqf92Swu63NB8BsO_XRfZN_AJYMQko
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+hydroxychloroquine+used+as+DMARD+on+SARS-CoV-2+tests+and+infection+evolution+in+a+population+of+871+patients+with+inflammatory+rheumatic+and+musculoskeletal+diseases&rft.jtitle=Joint%2C+bone%2C+spine+%3A+revue+du+rhumatisme&rft.au=Trefond%2C+Ludovic&rft.au=Drumez%2C+Elodie&rft.au=Andre%2C+Marc&rft.au=Costedoat-Chalumeau%2C+Nathalie&rft.date=2021-12-01&rft.issn=1778-7254&rft.eissn=1778-7254&rft.volume=88&rft.issue=6&rft.spage=105226&rft_id=info:doi/10.1016%2Fj.jbspin.2021.105226&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1297-319X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1297-319X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1297-319X&client=summon